Jessica Langbaum, PhD, emphasizes the need for diverse recruitment in Alzheimer's clinical trials, highlighting barriers like trial design and accessibility. Innovative approaches, such as decentralized trials and evidence-based recruitment messaging, aim to make trials more inclusive, ensuring benefits for all communities.